According to The Insight Partners, the Microbiome Drugs Market is expected to register an impressive CAGR of 37.1% from 2025 to 2031, reflecting strong growth potential and increasing commercialization of microbiome-based therapies. The growing focus on personalized medicine and rising demand for advanced therapeutics are expected to drive market expansion significantly during the forecast...